Barra F

No ORCID on file · 39 papers in corpus · active 2018-2026

Study types

  • review 18
  • article 13
  • other 4
  • editorial 2
  • letter 1

Condition tags

  • endometriosis 35
  • infertility 5
  • bowel_endometriosis 3
  • adenomyosis 1
  • dyspareunia 1
  • bladder_endometriosis 1
  • endometrioma 1
  • die_deep_infiltrating 1
review 2026
The lancet. Gastroenterology & hepatology ·doi:10.1016/S2468-1253(26)00117-2

Bowel involvement is a severe manifestation of deep endometriosis that affects approximately 8-12% of women with endometriosis. Bowel endometriosis is most commonly localised in the rectosigmoid colon and frequently coexists with other pelv…

review 2026
Expert opinion on pharmacotherapy ·doi:10.1080/14656566.2026.2695094

INTRODUCTION: Uterine fibroids and adenomyosis are common estrogen- and progesterone-dependent disorders associated with heavy menstrual bleeding, pelvic pain, anemia, and impaired quality of life. Although surgery remains widely used, ther…

review 2026
Medicina (Kaunas, Lithuania) ·doi:10.3390/medicina62020351

Background and Objectives: Endometriosis is a chronic, estrogen-dependent inflammatory disease with multifactorial pathogenesis. Increasing evidence suggests that alterations in the gut and reproductive tract microbiota may contribute to di…

review 2026
Expert opinion on pharmacotherapy ·doi:10.1080/14656566.2026.2685064

INTRODUCTION: Endometriosis is a chronic, estrogen-dependent inflammatory disorder requiring long-term management strategies that balance efficacy with systemic safety. Although hormonal therapies remain the cornerstone of treatment, the op…

review 2026
Expert opinion on drug safety ·doi:10.1080/14740338.2026.2627190

INTRODUCTION: Hormonal therapy is the cornerstone of long-term endometriosis management, especially for women deferring surgery. In patients with comorbid migraine - a common, disabling condition - therapeutic choices must balance efficacy …

review 2025
Expert opinion on drug safety ·doi:10.1080/14740338.2025.2547017

INTRODUCTION: Medical therapy is crucial in the long-term management of endometriosis, and its clinical efficacy must be balanced with a favorable safety profile. AREAS COVERED: This review aims to provide a comprehensive overview of avail…

review 2025
Expert opinion on investigational drugs ·doi:10.1080/13543784.2025.2609734

INTRODUCTION: Endometriosis is a chronic, estrogen-dependent inflammatory disease affecting up to 10% of reproductive-aged women. Current therapies are predominantly hormone-based and offer symptomatic relief without correcting the immune d…

review 2025
Gynecologic and obstetric investigation ·doi:10.1159/000542563

BACKGROUND: Bowel endometriosis is one of the more severe manifestations of deep endometriosis; it may cause pain and intestinal symptoms. The noninvasive diagnosis of bowel endometriosis is of crucial importance in planning the management …

article 2025

Giuseppe Mascellino,1 Antonio Simone Laganà,1 Marco Anatrà,2 Pietro Serra,1 Giada Mesiano,3 Matteo Terrinoni,4,5 Vincenzo Mascellino,6 Simone Ferrero,2 Maurizio Serati,3 Maurizio Leone,2 Fabio Barra2,7 1Unit of Obstetrics and Gynecology, “P…

review 2024
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2024.102528

Ovarian endometriomas (OEs) are commonly detected by ultrasound in individuals affected by endometriosis. Although surgery was widely regarded in the past as the gold standard for treating OEs, especially in the case of large cysts, the sur…

review 2024
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2024.102493

Deep endometriosis (DE) can be localized in the parametrium, a complex bilateral anatomical structure, sometimes necessitating intricate surgical intervention due to the potential involvement of autonomic nerves, uterine artery, and ureter.…

review 2024
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2024.102496

This narrative review aims to summarize available evidence on the IVF-associated outcomes after surgery for endometriosis. Only one retrospective study investigated if surgical treatment of superficial/peritoneal endometriosis may modify th…

review 2024
Expert opinion on drug safety ·doi:10.1080/14740338.2024.2446424

INTRODUCTION: Endometriosis and pelvic inflammatory disease (PID) are gynecological conditions affecting women of reproductive age and causing pain symptoms. The symptoms caused by these conditions are similar; thus, the differential diagno…

editorial 2024
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2024.102561
review 2024
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2024.102499

Diaphragmatic endometriosis (DpE) is a rare disease localization which represents an important clinical challenge. The main criticisms toward the proper DpE management consist of poor consensus on both surgical indications and the choice be…

article 2024
Fertility and sterility ·doi:10.1016/j.fertnstert.2024.02.031

OBJECTIVE: To study the ultrasonographic diagnostic accuracy and characteristics of parametrial endometriosis comprehensively. DESIGN: This prospective study enrolled patients with suspected deep endometriosis (DE) scheduled for laparoscop…

review 2023
Expert opinion on emerging drugs ·doi:10.1080/14728214.2023.2296080

INTRODUCTION: Endometriosis is an estrogen-dependent disease that gives rise to pelvic pain and infertility. Although estroprogestins and progestins currently stand as the first-line treatments for this condition, demonstrating efficacy in …

article 2023
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2023.04.005

STUDY OBJECTIVE: To evaluate the feasibility of laparoscopic rectosigmoid resection for bowel endometriosis (RSE), reporting surgical and short-term postoperative outcomes in a consecutive large series of patients. DESIGN: A retrospective …

other 2023
F1000Research ·doi:10.12688/f1000research.141537.1

BACKGROUND: Sexual health is a major concern in women with endometriosis, however only a few controlled studies have examined this with validated instruments. The effect of hormonal treatments on sexual function in endometriosis is also an …

article 2023
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2023.01.020

STUDY OBJECTIVE: There is great consensus that the implementation of the enhanced recovery after surgery (ERAS) approach is beneficial for surgical patients, but there is a paucity of data concerning its application in women with deep endom…

other 2023
Gynecologic and obstetric investigation ·doi:10.1159/000530461
letter 2023
Journal of reproductive immunology ·doi:10.1016/j.jri.2023.103967

This letter discusses the article "The Effects of Rituximab on Experimental Endometriosis Model in Rats" by Dogan et al., which evaluated the potential therapeutic efficacy of rituximab in an experimental animal model of endometriosis. Whil…

2022
International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics ·doi:10.1002/ijgo.13737

BackgroundOvarian carcinoma (OC) is one of the most widespread tumors in the world and is characterized by low survival rates.ObjectiveTo determine whether the levonorgestrel-releasing intrauterine system (LNG-IUS) can prevent OC.Search str…

article 2022
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2022.10.008

STUDY OBJECTIVE: To evaluate ultrasonographic findings as a first-line imaging tool to indirectly predict the presence of parametrial endometriosis (PE) in women with suspected deep endometriosis (DE) undergoing surgery. DESIGN: Retrospect…

editorial 2022
Journal of minimally invasive gynecology ·doi:10.1016/j.jmig.2022.12.016